Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Jin Ling Li
Age : 52
Country of residence : Unknown
Linked companies : China Northern Rare Earth (Group) High-Tech Co.,Ltd

Biography of Jin Ling Li 
Jin Ling Li is Chairman of China Northern Rare Earth (Group) High-Tech Co., Ltd.


Current positions of Jin Ling Li 
Jin Ling Li : Personal Network 
Most Read News 
11/15PATRICK DRAHI : Altice founder Drahi seeks bigger stake in Britain's BT - sources
RE
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/15ELON MUSK : Analysis-Musk's $6 billion Tesla stock haul has charity circuit buzzing
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
11/17HENRIK FISKER : Fisker unveils electric SUVs to beat Tesla over driving range
RE
11/16ELON MUSK : Tesla's Musk sells another 934,000 shares to pay taxes after exercising options - filing
RE
11/15WARREN BUFFETT : Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company
RE
11/16TED ROGERS : Rogers names Staffieri interim CEO as chair stamps authority after family feud
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
11/15ELON MUSK : Tesla's Musk sells $930 mln in shares to cover stock option tax - filings
RE
More news


© 2021 People and Ownership :   
Jin Ling Li : Connections 


Latest news about Jin Ling Li 
09/06Guosen Securities Co., Ltd. Announces Director Appointments
CI
08/20Ping An Insurance Company of China, Ltd Announces Directors Appointments
CI
05/17YFY Inc. Announces Executive Changes
CI
05/17YFY Inc. Announces Board Changes
CI
04/16Certain A Shares of HitGen Inc. are subject to a Lock-Up Agreement Ending on 16-APR-2021.
CI
03/28Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint
CI
03/25Ping An Insurance Company of China, Ltd. Approves Board Appointments
CI
More news